Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
äŒæ¥ã³ãŒãCSBR
äŒç€ŸåChampions Oncology Inc
äžå Žæ¥Nov 30, 1988
æé«çµå¶è²¬ä»»è
ãCEOãBrainin (Robert)
åŸæ¥å¡æ°213
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Nov 30
æ¬ç€Ÿæåšå°One University Plaza,
éœåžHACKENSACK
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·07601
é»è©±çªå·12018088400
ãŠã§ããµã€ãhttps://championsoncology.com
äŒæ¥ã³ãŒãCSBR
äžå Žæ¥Nov 30, 1988
æé«çµå¶è²¬ä»»è
ãCEOãBrainin (Robert)